Anatomic, geographic, and taxon-specific relative risks of carbapenem resistance in the health care system of the U.S. Department of Defense

Journal of Clinical Microbiology

Volumn 54, Issue 6, 2016, Pages 1546-1551

  Lesho, Emil ^a   Chukwuma, Uzo ^b   Sparks, Michael ^a   Neumann, Charlotte ^b   Richesson, Douglas ^c   Clifford, Robert ^a   Gierhart, Sarah ^b   Waterman, Paige ^d   Hinkle, Mary ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Navy and Marine Corps Public Health Center   (United States)

^c LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^d Armed Forces Health Surveillance Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; DORIPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; HEALTH CARE SYSTEM; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN IDENTIFICATION; UNITED STATES; ACINETOBACTER; ADOLESCENT; ADULT; AGED; CHILD; DRUG EFFECTS; FEMALE; GEOGRAPHY; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH CARE FACILITY; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MILITARY PHENOMENA; NEWBORN; PRESCHOOL CHILD; RISK; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; FEMALE; GEOGRAPHY; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH FACILITIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MILITARY FACILITIES; PSEUDOMONAS AERUGINOSA; RISK; UNITED STATES; YOUNG ADULT;

EID: 84969983922     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00359-16     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508. pdf.
2. Perez F, Van Duin D. 2013. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Cleve Clin J Med 80:225-233. http://dx.doi.org/10.3949/ccjm.80a.12182.
3. Lesho EP, Clifford RJ, Chukwuma U, Kwak YI, Maneval M, Neumann C, Xie S, Nielsen LE, Julius MD, McGann P, Waterman PE. 2015. Carbapenem-resistant Enterobacteriaceae and the correlation betwe en carbapenem and fluoroquinolone usage and resistance in the U.S. military health system. Diagn Microbiol Infect Dis 81:119-125. http://dx.doi.org/10.1016/j.diagmicrobio.2014.09.017.
4. Petersen K, Riddle M S, Danko Blazes DL, Hayden R, Tasker SA, Dunne JR. 2007. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 245:803-811. http://dx.doi.org/10.1097/01.sla.0000251707.32332.c1.
5. Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Cliffor d R, Waterman PE. 2013. Emergence of colistin resistance in Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of extremelydrug-resistant wound infections. J Infect Dis 208:1142-1151. http:/ /dx.doi.org/10.1093/infdis/jit293.
6. Joly-Guillou ML. 2005. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 11:868-873. http://dx.doi.org/10.1111/j.1469-0691.2005.01227.x.
7. Sengupta S. 18 June 2015. 60 million people fleeing chaotic lands, U.N. says. International New York Times, New York, NY. http://www.nytimes.com/2015/06/18/world/60-million-people-fleeing-chaotic-lands-un-say s.html?-r-0.
8. Peretz A, Labay K, Zonis Z, Glikman D. 2014. Disengagement does not apply to bacteria: A high carriage rate of antibiotic-resistant pathogens among Syrian civilians treated in Israeli hospitals. Clin Infect Dis 59:753-754. http://dx.doi.org/10.1093/cid/ciu374.
9. Kantele A, Laaveri T, Mero S, Vilkman K, Pakkanen SH, Ollgren J, Antikainen J, Kirveskari J. 2015. Antimic robials increase travelers' risk of colonization by extended-spectrum-lactamase-producing Enterobacteriaceae. Clin Infect Dis 60:837-846. http://dx.doi.org/10.1093/cid/ciu957.
10. Connor BA, Keystone JS. 2015. Antibiotic self-treatments of travelers' diarrhea: Helpful or harmful? Clin Infect Dis 60:847-848. http://dx.doi.org/10.1093/cid/ciu961.
11. Ruppe E, Armand-Lefevre L, Estallat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farè se M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S. 2015. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis 61:593-600. http://dx.doi.org/10.1093/cid/civ333.
12. Landrum M, Neumann C, Cook C, Chukwuma U, Ellis MW, Hospenthal DR, Murray CK. 2012. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infec tions in the U.S. Military Health System, 2005-2010. JAMA 308:50-59. http://dx.doi.org/10.1001/jama.2012.7139.
13. Clinical and Laboratory Standards Institute. 2006. Analysis and presentation of cumula tive antimicrobial susceptibility test data; 2nd ed. Approved guideline M39-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Hindler JF, Stelling J. 2007. Analysis and presentation of cumulative antibiograms: A new consensus guideline from the clinical and laboratory standards institute. Clin Infect Dis 44:867-873. http://dx.doi.org/10.1086/511864.
15. Clinical and Laboratory Standards Institute. 2006 - 2014. Performance standards for antimicrobial susceptibility testing: 16th to 24th informational supplements. M100-S16-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
16. Nielsen L, Clifford R, Kwak Y, Preston L, Argyros C, Rabinowitz R, Waterman P, Lesho E. 2015. 11,000-isolate same plate/same day comparison of the three most widely used platforms for analyzing multidrugresistant clinical pathogens. Diagn Microbiol Infect Dis 83:93-98. http://dx.doi.org/10.1016/j.diagmicrobio.2015.05.018.
17. Lesho E, Waterman P , Chukwuma U, McAuliffe K, Neumann C, Julius M, Crouch H, Chandrasekara R, English Clifford R, Kester. 2014. The Antimicrobial Resistance Monitoring and Research (ARMoR) program: The Department of Defense's respon se to escalating antimicrobial resistance. Clin Infect Dis 59:390-397. http://dx.doi.org/10.1093/cid/ciu319.
18. Szklo M, Nieto J. 2007. Epidemiology: Beyond the basics. Jones & Bartlett Learning, New York, NY.
19. Gauvreau K Pagano M. 2000 Principles of biostatistics, 2nd ed Duxbury Press, Independence, KY.
20. Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. 2013. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 26:289-307. http://dx.doi.org/10.1128/CMR.00001-13.
21. Mutnick AH, Rhomberg PR, Sader HS, Jones RN. 2004. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999 -200 1). J Antimicrob Chemother 53:290-296. http://dx.doi.org/10.1093/jac/dkh039.
22. Ho CM, Ho MW, Liu YC, Toh HS, Lee YL, Liu YM, Huang CC, Lu PL, Liu CE, Chen YH, Ko WC, Tang HJ, Yu KW, Chen YS, Chuang YC, Wang JH, Hsueh PR. 2012. Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections a t five medical centers in Taiwan, 2006- 2010. Int J Antimicrob Agents 40(Suppl):S24-S28. http://dx.doi.org/10.1016/S0924-8579(12)70006-7.